Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Immun Ageing ; 11: 7, 2014.
Article in English | MEDLINE | ID: mdl-24822075

ABSTRACT

BACKGROUND: The prevalence of latex allergy varies according to the population studied from 3% to 64%. No data exist in the present literature about elderly people because they were not considered among populations at risk. We report a retrospective observational study of 88 elderly patients of our centre of Dermatology and Allergology at Policlinico Umberto I, University of Rome, Sapienza. RESULTS: First and second level diagnostic tests showed latex positivity in 11,4% of patients studied for latex allergy in the elderly population. CONCLUSIONS: Our study demonstrates a prevalence of elderly-latex sensitization of 11,4%, showing that allergy to latex is a growing disease that can occur at any age. So, we propose these patients as an additional risk category for latex allergy.

2.
Article in English | MEDLINE | ID: mdl-21352092

ABSTRACT

Effective management of wound healing is a considerable challenge for clinicians. Patients underlying condition, accurate assessment of the wound and exudates, as well as selection of an appropriate dressing is all important factors for success. A variety of dressings are available to the clinician for the management of exudates. Hydrofiber dressings are a relatively new concept, and can be very cost effective because they can be worn for several days at a time. This report will review clinical evidences on the use of Hydrofiber dressing for the management of epithelial lesions, deal with current knowledge on the mechanism of action of this compound towards the epithelial wound healing process, immunological aspects and will also discuss relevant patents.


Subject(s)
Bandages, Hydrocolloid , Carboxymethylcellulose Sodium/therapeutic use , Wound Healing , Wounds and Injuries/therapy , Animals , Exudates and Transudates , Humans , Patents as Topic , Treatment Outcome , Wounds and Injuries/immunology
3.
Article in English | MEDLINE | ID: mdl-19832694

ABSTRACT

Topical ketoprofen (KP) is widely used because of its anti-inflammatory effect. Parallel with its popular usage, the number of reported cases of ketoprofen-induced photoallergic contact dermatitis has increased. A review of the literature was made to evaluate the spectrum of cross sensitization in patients with ketoprofen-induced photoallergic contact dermatitis using ketoprofen and other structurally similar chemicals and sunscreens, fragrance components, as well as the presence of prolonged photosensitivity related to it. Furthermore, the distinction between true cross-reactivity and concomitant sensitization may be difficult. Therefore, further investigations are needed to gain a more complete understanding of this important topic. This article also reviews some patents related to alternative treatment of musculoskeletal diseases and/or treatment of allergic reactions due to NSAIDs use.


Subject(s)
Anti-Inflammatory Agents, Non-Steroidal/adverse effects , Dermatitis, Photoallergic/immunology , Drug Hypersensitivity/immunology , Ketoprofen/adverse effects , Musculoskeletal Diseases/drug therapy , Animals , Anti-Inflammatory Agents, Non-Steroidal/therapeutic use , Cross Reactions/immunology , Dermatitis, Photoallergic/etiology , Drug Delivery Systems , Drug Hypersensitivity/etiology , Humans , Ketoprofen/chemistry , Ketoprofen/therapeutic use , Patents as Topic
4.
Infect Dis Rep ; 2(2): e11, 2010 Aug 04.
Article in English | MEDLINE | ID: mdl-24470891

ABSTRACT

Environmental mycobacteria are the causative factors of an increasing number of infections worldwide. Cutaneous infections as a result of such mycobacteria are often misdiagnosed, and their treatment is difficult since they can show in vivo and in vitro multidrug resistance. Absence of pathognomonic clinical signs and variable histological findings often delay diagnosis. We report a case of localized recurrent soft tissue swelling by Mycobacterium marinum in 2 members of the same family. The cases are being reported for their uncommon clinical presentation and the associated etiological agent. Patients recovered completely following therapy with rifampicin 600 mg plus isoniazide 300 mg daily for 45 days.

SELECTION OF CITATIONS
SEARCH DETAIL
...